Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis (REVAMP)
Sepsis, Sepsis Mrsa, Sepsis Bacteremia
About this trial
This is an interventional other trial for Sepsis focused on measuring Sepsis, Vancomycin use, methicillin-resistant Staphylococcus aureus (MRSA), Antibiotic Stewardship, Implementation science
Eligibility Criteria
Patient Inclusion Criteria: Admitted to one of the participating PICUs during the study period Patient Exclusion Criteria: None Clinician Inclusion Criteria: PICU prescribing clinician (including attending physicians, fellows, residents, nurse practitioners, and physician assistants) OR sepsis stakeholder (leader of sepsis quality improvement work, medical director) at one of the participating sites at the time the survey is deployed Age ≥ 18 years old Employed by one of the participating sites Clinician Exclusion Criteria: Volunteers or other non-employee hospital staff Limited English proficiency
Sites / Locations
- Children's Healthcare of AtlantaRecruiting
- Johns Hopkins Children's CenterRecruiting
- St. Louis Children's HospitalRecruiting
- Children's Hospital of PhiladelphiaRecruiting
Arms of the Study
Arm 1
Arm 2
Other
No Intervention
PICU Clinicians and Sepsis stakeholders
PICU Patients with suspected sepsis
Clinicians and sepsis stakeholders in the participating sites will be primarily recruited via email. During the course of this multifaceted intervention: All the PICU (Pediatric Intensive Care Unit) prescribing clinicians and sepsis stakeholders in the participating sites will receive clinical guidelines, unit-level feedback reports, and education on Vancomycin use during the intervention. Investigators will perform semi-structured interviews with 90 PICU clinicians and sepsis stakeholders. Surveys will be sent to all eligible clinicians, estimated to be up to 2500 individuals across the 4 sites. These structured surveys will be done at baseline and at 9 months post-implementation.
Research procedures involving patients will be limited to medical record review. This medical record review will help inform the intervention directed at PICU clinicians/stakeholders and the assessment of study outcomes. Approximately 50,000 patients will participate in the study. Data elements will be collected at each site and stored as password-protected Comma-separated values (CSV) files. These files will not contain any direct Protected Health Information (PHI) but will contain elements of date (e.g., date of admission, date of suspected sepsis episode). The study Identification (ID) number will be used to identify each unique patient. Each site will collect and store data in compliance with the Children's Hospital of Philadelphia (CHOP) and local Institutional Review Board (IRB) policies.